在宫动脉剖析和随后的缺血性中风中使用他
Omair Ul Haq Lodhi1, Shadi Yaghi2, Liqi Shu2
1Department of Neurology, University of Minnesota, Minneapolis, MN, USA.
Current health sciences journal
|November 20, 2025
概括
在宫动脉剖析 (CAD) 患者中,他类药物治疗并没有显著降低复发性缺血性中风的风险. 需要进一步的研究来优化CAD相关中风的二次预防策略.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 血管医学 血管医学
背景情况:
- 宫动脉解剖 (CAD) 是缺血性中风的重要原因,特别是在年轻人中.
- 在CAD后预防复发性缺血性中风时,他类药物治疗的有效性尚未得到充分证实.
研究的目的:
- 为了研究他类药物治疗对随后缺血性中风风险的影响,在患有非创伤性宫动脉剖析的患者中.
- 评估他类药物对该患者群体重大出血,死亡率和功能结果的影响.
主要方法:
- 在宫动脉剖析中预防中风的抗血栓治疗 (STOP-CAD) 研究的二次分析.
- 包括2610名因非重大创伤相关的CAD而患有缺血性中风的患者,按在出院时使用他类药物分层.
- 基于他类药物的强度 (高,中等,低或不存在) 的敏感性分析.
主要成果:
- 在后续的缺血性中风中,他类药物使用者 (3.1%) 和不使用者 (3.3%) 之间没有显著差异 (aHR 0.73;95% CI,0.43-1.24;p=0.25).
- 两组之间在重大出血,死亡率或90天功能结果方面没有发现显著差异.
结论:
- 在CAD患者中,他类药物治疗没有显著减少复发性缺血性中风,严重出血,死亡率或改善功能结果.
- 研究结果表明,与一般的缺血性中风人群相比,在CAD相关的缺血性中风中,他类药物的益处不那么明显.
- 强调需要个性化治疗策略和进一步研究,以优化CAD的二次预防.
更多相关视频
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
503
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
5.7K
相关概念视频
01:26Atherosclerosis III: Management
290
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290
01:27Coronary Artery Disease V: Interprofessional Care
202
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
202
01:28Acute Coronary Syndrome IV: Interprofessional Care
194
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
194
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:30Acute Coronary Syndrome I: Introduction
690
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
690
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
358
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
358